Search Result Products - CapitalBiotech Co., Ltd.

All Related Products Other Content

CapitalBiotech® CalSlide-III Calibration Slide CalSlideTM is a fluorescence calibration product made of NanobriteTM inorganic nano-fluorescent material on a scanner-scannable universal size (25.2mm*75.5mm*1mm) glass slide.
Individualized Medication Guidance for Gastrointestinal Cancer This test detects 84 genes related to gastrointestinal cancer.
The Disease Susceptibility Genetic Test-Breast Cancer The test is based on biochip technology，evaluates the risk of breast cancer from the perspective of genetics and provide guidance on disease prevention.
Bloodstream Infection Pathogen Targeted Next-generation Sequencing (tNGS) Kit Bloodstream Infection Pathogen Targeted Next-generation Sequencing (tNGS) is an accurate detection method that combines the advantages of ultra-high multiplex target amplification and high-throughput ...
Hybridization Box CapitalBiotech HybSetTM Microarray Hybridization Box holds a 25mm 75mm microarray slide to prevent solution evaporation.
Drug-Related Deafness Gene Mutations Detection The Drug-Related Deafness Gene Mutations Detection service focuses on detecting drug-induced deafness genes.
Genetic Testing for BRCA1/2 Targeted-Drug Guidance (Germline + Somatic) This test detects somatic and germline mutations in the BRCA1 and BRCA2 genes, and provides information to guide PARP inhibitor therapy in breast & ovarian cancer.
The Disease Susceptibility Genetic Test-Colorectal Cancer This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.
Central Nervous System Infection Pathogen Targeted Next-generation Sequencing (tNGS) Kit Central Nervous System Infection Pathogen Targeted Next-generation Sequencing (tNGS) is an accurate detection method that combines the advantages of ultra-high multiplex target amplification and high-...
100 Loci of 18 Deafness-Related Genes Detection Using next-generation sequencing technology, it can test 100 loci in 18 deafness-related genes in humans to determine if there are mutation sites in the deafness gene.
Individualized Medication Guidance for Breast Cancer This test detects 348 genes, and involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.
The Disease Susceptibility Genetic Test-Esophageal Cancer This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.
Genitourinary Tract Infection Pathogen Targeted Next-generation Sequencing (tNGS) Kit Genitourinary Tract Infection Pathogen Targeted Next-generation Sequencing (tNGS) is an accurate detection method that combines the advantages of ultra-high multiplex target amplification and high-thr...
MAPMI Ultra-Broad-Spectrum Pathogen mNGS Test Utilizing BES 4000 sequencing platform, MAPMI can screen 31,400 pathogenic microorganisms from clinical samples like blood, alveolar lavage fluid, cerebrospinal fluid, sputum, chest ascites, urine, secretions, and tissues.
Hereditary Deafness Gene Detection (227 Genes+Mitochondrial Genome) Using next-generation sequencing technology, 227 deafness-related genes and the entire mitochondrial genome sequence are identified to provide precise guidance for molecular disease diagnosis.